Myostatin Directly Regulates Skeletal Muscle Fibrosis*

Skeletal muscle fibrosis is a major pathological hallmark of chronic myopathies in which myofibers are replaced by progressive deposition of collagen and other extracellular matrix proteins produced by muscle fibroblasts. Recent studies have shown that in the absence of the endogenous muscle growth regulator myostatin, regeneration of muscle is enhanced, and muscle fibrosis is correspondingly reduced. We now demonstrate that myostatin not only regulates the growth of myocytes but also directly regulates muscle fibroblasts. Our results show that myostatin stimulates the proliferation of muscle fibroblasts and the production of extracellular matrix proteins both in vitro and in vivo. Further, muscle fibroblasts express myostatin and its putative receptor activin receptor IIB. Proliferation of muscle fibroblasts, induced by myostatin, involves the activation of Smad, p38 MAPK and Akt pathways. These results expand our understanding of the function of myostatin in muscle tissue and provide a potential target for anti-fibrotic therapies.

[1]  D. Allen,et al.  Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. , 2008, American journal of physiology. Endocrinology and metabolism.

[2]  Juan Li,et al.  Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. , 2008, Human gene therapy.

[3]  Konstantin I Bakhurin,et al.  Tendons of myostatin-deficient mice are small, brittle, and hypocellular , 2008, Proceedings of the National Academy of Sciences.

[4]  F. Ambrosio,et al.  Relationships between transforming growth factor-beta1, myostatin, and decorin: implications for skeletal muscle fibrosis. , 2007, The Journal of biological chemistry.

[5]  David S. Rogers,et al.  Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. , 2007, Cellular signalling.

[6]  K. Fujiwara,et al.  ECM remodeling in hypertensive heart disease. , 2007, The Journal of clinical investigation.

[7]  A. Benigni,et al.  Therapeutic potential of TGF-β inhibition in chronic renal failure , 2007 .

[8]  Zhenguo Wu,et al.  Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3β Pathway and Is Antagonized by Insulin-like Growth Factor 1* , 2006, Journal of Biological Chemistry.

[9]  S. Cook,et al.  Myostatin Regulates Cardiomyocyte Growth Through Modulation of Akt Signaling , 2006, Circulation research.

[10]  S. Mutsaers,et al.  Growth factors in pleural fibrosis , 2006, Current opinion in pulmonary medicine.

[11]  E. Arnoldi,et al.  Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy , 2006, Journal of Neuroimmunology.

[12]  J. Molkentin,et al.  Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. , 2006, The American journal of pathology.

[13]  M. Jinnin,et al.  Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-β1-Induced Extracellular Matrix Expression , 2006, Molecular Pharmacology.

[14]  R Weiskirchen,et al.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets , 2006, Journal of cellular and molecular medicine.

[15]  K. Wagner Muscle regeneration through myostatin inhibition , 2005, Current opinion in rheumatology.

[16]  L. Mcleay,et al.  Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice , 2005, Journal of Cell Science.

[17]  K. Wagner,et al.  Muscle regeneration in the prolonged absence of myostatin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Braun,et al.  Myostatin mutation associated with gross muscle hypertrophy in a child. , 2004, The New England journal of medicine.

[19]  L. Liang,et al.  Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. , 2004, Cytokine.

[20]  K. Patel,et al.  Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. , 2004, Developmental biology.

[21]  H. Schnaper,et al.  The Phosphatidylinositol 3-Kinase/Akt Pathway Enhances Smad3-stimulated Mesangial Cell Collagen I Expression in Response to Transforming Growth Factor-β1* , 2004, Journal of Biological Chemistry.

[22]  J. Wrana,et al.  Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.

[23]  Seumas McCroskery,et al.  Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.

[24]  B. Langley,et al.  Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression* , 2002, The Journal of Biological Chemistry.

[25]  K. Wagner,et al.  Loss of myostatin attenuates severity of muscular dystrophy in mdx mice , 2002, Annals of neurology.

[26]  R. Ahima,et al.  Functional improvement of dystrophic muscle by myostatin blockade , 2002, Nature.

[27]  R. Hewick,et al.  The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum* , 2002, The Journal of Biological Chemistry.

[28]  Yong Li,et al.  Muscle injuries and repair: current trends in research. , 2002, The Journal of bone and joint surgery. American volume.

[29]  Se-Jin Lee,et al.  Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Kucherlapati,et al.  Functional Characterization of Transforming Growth Factor β Signaling in Smad2- and Smad3-deficient Fibroblasts* , 2001, The Journal of Biological Chemistry.

[31]  J. Devesa,et al.  Myostatin regulates cell survival during C2C12 myogenesis. , 2001, Biochemical and biophysical research communications.

[32]  Quazi Shakey,et al.  Gdf-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding , 2001, Growth factors.

[33]  B. Langley,et al.  Myostatin, a Negative Regulator of Muscle Growth, Functions by Inhibiting Myoblast Proliferation* , 2000, The Journal of Biological Chemistry.

[34]  M. Järvinen,et al.  Relation between myofibers and connective tissue during muscle injury repair , 2000, Scandinavian journal of medicine & science in sports.

[35]  K. Matthews,et al.  Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.

[36]  Se-Jin Lee,et al.  Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. P. Oh,et al.  The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. , 1997, Genes & development.

[38]  Se-Jin Lee,et al.  Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.

[39]  L. Morandi,et al.  Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. , 1995, The Journal of clinical investigation.

[40]  J. Shrager,et al.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.

[41]  H. Blau,et al.  Isolation and characterization of human muscle cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Yaffe,et al.  The in vitro cultivation and differentiation capacities of myogenic cell lines. , 1970, Developmental biology.